New £400,000 melanoma vaccine heralds start of 'cancer renaissance' as UK trials personalised jabs for lung, bowel, pancreas and liver tumours... but experts fear NHS can't afford them
The UK is entering a ' cancer renaissance' with pioneering personalised vaccines to combat some of the deadliest tumours expected by 2030, say leading experts. (Source: the Mail online | Health)
Source: the Mail online | Health - April 26, 2024 Category: Consumer Health News Source Type: news
How DOES the pioneering skin cancer vaccine work? When will patients be able to get hold of it? And could it really be a cure for deadly melanoma? All your questions answered...
Brits could be just over a year away from receiving a 'game-changer' jab on the NHS to treat one of the deadliest forms of skin cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - April 26, 2024 Category: Consumer Health News Source Type: news
I took the world-first personalised cancer vaccine - it's my only hope of stopping deadly disease in its tracks
The music teacher, from Stevenage, is one of a handful of Brits to receive a world first personalised mRNA jab aimed at stopping this kind of skin cancer in its tracks. (Source: the Mail online | Health)
Source: the Mail online | Health - April 26, 2024 Category: Consumer Health News Source Type: news
‘Real hope’ for cancer cure as personal mRNA vaccine for melanoma trialled
Excitement among patients and researchers as custom-built jabs enter phase 3 trialDoctors have begun trialling in hundreds of patients the world ’s first personalised mRNA cancer vaccine for melanoma, as experts hailed its “gamechanging” potential to permanently cure cancer.Melanoma affects about 132,000 people a year globally and is the biggest skin cancer killer. Currently, surgery is the main treatment although radiotherapy, medicines and chemotherapy are also sometimes used.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - April 26, 2024 Category: Science Authors: Andrew Gregory Health editor Tags: Cancer Skin cancer Drugs Medical research Science Health Vaccines and immunisation UK news UCL (University College London) Source Type: news
Cancer breakthrough as scientists develop super vaccine that could provide miracle cure
Now in global studies, the jab may also be effective against lung, bladder and kidney cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - April 26, 2024 Category: Consumer Health News Source Type: news
First mRNA skin-cancer vaccine starts UK trial
Steve Young is part of the tests to see if an mRNA jab can stop the deadliest skin cancer returning. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - April 26, 2024 Category: Consumer Health News Source Type: news
'Game-changer' cancer jab offers hope of a cure: NHS launches trial of world's first personalised vaccine to destroy melanomas - and it uses same tech as pioneering Covid shots
The vaccine is custom-built for individuals using the specific genetic makeup of their tumour - telling the body to hunt down cancer cells and prevent the deadly disease from coming back. (Source: the Mail online | Health)
Source: the Mail online | Health - April 26, 2024 Category: Consumer Health News Source Type: news
CHC: Creating Healthier Communities awards funds to Georgia communities to help prevent one of the most common forms of cancer
Healthy Savannah, East Georgia Cancer Coalition, and Georgia Campaign for Adolescent Power & Potential join CHC to focus on vaccination equity to prevent cervical cancer in Macon, Savannah, Augusta, and the surrounding areas. ALEXANDRIA, Va., April 23, 2024 /PRNewswire-PRWeb/ -- CHC:... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 23, 2024 Category: Pharmaceuticals Tags: NPT LIC Source Type: news
Spark co-founder, Harvard professor launch Watertown biotech with $54M
The Watertown startup has an ambitious goal of developing vaccines that provide lifelong protection from cancer and infectious diseases. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 19, 2024 Category: Pharmaceuticals Authors: Hannah Green Source Type: news
Millions of Girls in Africa Will Miss HPV Shots After Merck Production Problem
The company has told countries that it can supply only 18.8 million of the 29.6 million doses it was contracted to deliver this year. (Source: NYT Health)
Source: NYT Health - April 18, 2024 Category: Consumer Health News Authors: Stephanie Nolen Tags: Sexually Transmitted Diseases Vaccination and Immunization Developing Countries Cervical Cancer Human Papillomavirus (HPV) Women and Girls Medicine and Health Teenagers and Adolescence Children and Childhood Gardasil (Vaccine) Source Type: news
Chinese pharma firm WuXi that makes life-saving cancer drugs accused of STEALING American's genetic information
A major Chinese pharmaceutical company is using Americans' genetic information to build a massive worldwide database to create new drugs and vaccines, Senators said. (Source: the Mail online | Health)
Source: the Mail online | Health - April 15, 2024 Category: Consumer Health News Source Type: news
Nature Medicine Publishes Interim Results from Gritstone bio's Phase 1/2 Study of " Off-the-Shelf " Neoantigen Vaccine Platform (SLATE)
Discovery of a novel immunodominance hierarchy of tumor neoantigens (including KRAS) enabled the development of a more potent, KRAS-specific vaccine candidate (SLATE-KRAS) being studied by Steven A. Rosenberg of the National Cancer Institute (NCI) -- -- Publication underscores the important role…#discovery #kras #stevenarosenberg #nci #emeryville #gritstonebioinc #naturemedicine #gritstone #phase1 #phase2 (Source: Reuters: Health)
Source: Reuters: Health - April 15, 2024 Category: Consumer Health News Source Type: news
Elicio Therapeutics (NASDAQ: ELTX) Makes Strides In Growing Cancer Vaccination Industry
Founded in 2011, Elicio Therapeutics Inc. ELTX has made several significant strides in the last 13 years. The immunotherapy company has completed multiple successful preclinical trials and has been featured in publications like Nature Medicine and Cancer Immunology Research, a journal of the…#eliciotherapeutics #amp #eli002 #kras #cpg #grandviewresearch #trialinprogress #amplify7p #eli0027p #pdac (Source: Reuters: Health)
Source: Reuters: Health - April 10, 2024 Category: Consumer Health News Source Type: news
AACR: Novel Personalized Vaccine Feasible for Head and Neck Cancer
TUESDAY, April 9, 2024 -- The novel viral-based personalized cancer vaccine, TG4050, which encodes up to 30 patient- and tumor-specific sequences is feasible and safe for patients with resected head and neck squamous cell carcinoma, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 9, 2024 Category: Pharmaceuticals Source Type: news
Moderna ’s (NASDAQ:MRNA) Latest Cancer Treatment Gives Shares New Life
For a while, things weren’t looking all that great for biotech stock Moderna (NASDAQ:MRNA). Its primary stock in trade, the COVID-19 vaccine, has b... (Source: Reuters: Health)
Source: Reuters: Health - April 9, 2024 Category: Consumer Health News Source Type: news
